WMSA
CBIO

Weiss Multi-Strategy Advisers’s Crescent Biopharma CBIO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$125K – 563
2019
Q1 		$125K Sell
100
-50
-33% -$57.2K ﹤0.01% 485
2018
Q4 		$142K Sell
150
-218
-59% -$262K 0.01% 421
2018
Q3 		$530K Buy
368
+2
+0.5% +$3.02K 0.01% 438
2018
Q2 		$591K Sell
366
-34
-9% -$58.5K 0.01% 480
2018
Q1 		$649K Buy
+400
New +$832K 0.02% 453

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CBIO Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of Crescent Biopharma (CBIO) in Q2 2019, closing a stake of 100 shares — an estimated $125K sold.

Weiss Multi-Strategy Advisers first reported a position in CBIO in Q1 2018 and held it in 5 quarters. The position peaked at $649K in Q1 2018. 78 funds tracked by Wall St. Rank hold CBIO as of Q2 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Crescent Biopharma position as of Q2 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 100 Crescent Biopharma shares in Q2 2019, an estimated $125K.
  • Weiss Multi-Strategy Advisers first reported a position in Crescent Biopharma in Q1 2018 and held it in 5 quarters.
  • Weiss Multi-Strategy Advisers's Crescent Biopharma position peaked at $649K in Q1 2018.
  • 78 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.